NIH grant deadlines follow a fixed three-cycle annual schedule set by activity code, with separate due dates for new, renewal and resubmission applications. For 2026, sponsored-programs offices must additionally track the end of continuous submission (final acceptance August 10, 2026), a new late-application policy taking effect May 25, 2026, and the discontinuation of dedicated AIDS due dates.
The NIH standard due-date system is the fixed calendar of application deadlines published by the National Institutes of Health that assigns each grant activity code (R01, R21, K series, F series, and others) to one of three annual submission cycles. All applications and associated documents are due by 5:00 PM local time of the applicant organisation on the specified date.
- What Are NIH’s Standard Due Dates for 2026?
- How Do NIH’s Three Submission Cycles Work?
- What Are NIH’s Resubmission Rules and the 37-Month Window?
- What Is Changing for NIH Submitters in 2026?
- Building a Multi-PI Master Calendar: FAQs for Sponsored-Programs Staff
What Are NIH’s Standard Due Dates for 2026?
NIH assigns each grant mechanism a fixed due date within each of the three annual cycles, published by grants.nih.gov. New and renewal/resubmission applications for the same activity code fall on different days within the same month, which is the detail most single-applicant guides compress or omit.
| Activity code | Application type | Cycle I | Cycle II | Cycle III |
|---|---|---|---|---|
| R01, U01 | New | 5 Feb | 5 Jun | 5 Oct |
| R01, U01 | Renewal / resubmission / revision | 5 Mar | 5 Jul | 5 Nov |
| K series | New | 12 Feb | 12 Jun | 12 Oct |
| K series | Renewal / resubmission / revision | 12 Mar | 12 Jul | 12 Nov |
| R03, R21, R34 | New | 16 Feb | 16 Jun | 16 Oct |
| R03, R21, R34 | Renewal / resubmission / revision | 16 Mar | 16 Jul | 16 Nov |
| R15 (AREA) | All types | 25 Feb | 25 Jun | 25 Oct |
| F series fellowships | All types | 8 Apr | 8 Aug | 8 Dec |
| R13, U13 (conferences) | All types | 12 Apr | 12 Aug | 12 Dec |
| P series, R18/U18, R25, T/D series | All types | 25 Jan | 25 May | 25 Sep |
| SBIR/STTR (R41-R44, U43/U44) | All types | 5 Sep | 5 Jan | 5 Apr |
SBIR/STTR mechanisms run on their own offset schedule rather than the calendar-year cycle used for research grants, so administrators tracking a mixed PI portfolio need two calendars side by side, not one.
How Do NIH’s Three Submission Cycles Work?
NIH review runs on a fixed sequence after each submission window: scientific merit review, then an advisory council round, then an earliest allowable project start date. Under NIH’s submission policies, Cycle I applications go to merit review in June-July, Cycle II in October-November, and Cycle III in February-March of the following year.
| Cycle | Application window | Scientific merit review | Earliest project start |
|---|---|---|---|
| Cycle I | Jan-Apr | June-July | September / December |
| Cycle II | May-Aug | October-November | April |
| Cycle III | Sep-Dec | February-March | July |
Each cycle carries roughly a nine-month lag between application due date and earliest possible award start. For a sponsored-programs office running several PIs across R01, K series and R21 mechanisms, this means the same calendar month can hold a Cycle III new-application deadline for one PI and a Cycle II resubmission deadline for another — the two do not move in lockstep even though both sit on the “NIH calendar.”
What Are NIH’s Resubmission Rules and the 37-Month Window?
NIH permits one resubmission (designated A1) of an unfunded application. The resubmission must be submitted for the next appropriate due date and, under long-standing NIH policy, no later than 37 months after the original (A0) application’s submission date. If an A1 is also not funded, the applicant may submit a substantially revised idea as a new A0 application rather than a second resubmission.
- Only one resubmission (A1) is permitted per original application.
- The A1 must be submitted within 37 months of the A0 submission date.
- A1 applications use the renewal/resubmission due dates in the table above, not the “new” dates.
- After an unsuccessful A1, the next step is a new A0, not a further resubmission.
For administrators tracking multiple PIs, the 37-month clock is the deadline most likely to be missed silently, because it is not tied to a fixed calendar date and does not appear on any single NIH published list — it has to be calculated per application from each PI’s original A0 submission date.
What Is Changing for NIH Submitters in 2026?
Three policy changes affect submissions dated 2026, per grants.nih.gov’s submission policies page (updated 31 March 2026):
- End of continuous submission. NIH will accept continuous-submission applications (for eligible reviewers, standing study section members and chartered advisory council members) through August 10, 2026 — the close of the continuous-submission receipt period for R01, R21, U01 and related mechanisms.
- New late-application policy. A revised late-application policy takes effect for due dates on or after 25 May 2026. Late applications will be accepted only in narrow, specific circumstances defined in the funding opportunity announcement, not as a general grace window.
- Dedicated AIDS due dates discontinued. Beginning with applications considered at the January 2027 Advisory Council round — meaning any application with a due date on or after 25 May 2026 — NIH will no longer maintain separate AIDS and AIDS-related due dates; these applications move to the standard due dates for their activity code.
All three changes compress the informal flexibility administrators previously used to absorb late PI submissions. A missed internal routing deadline that once could be recovered through continuous submission or a late-policy exception now has materially less room to move from 25 May 2026 onward.
Building a Multi-PI Master Calendar: FAQs for Sponsored-Programs Staff
A single-PI due-date list is not sufficient for an office managing a portfolio. The practical fix is a master calendar keyed on activity code + application type + cycle, not on PI name, with each PI’s internal routing deadline set 5-10 business days before the NIH due date to allow for institutional sign-off, biosketch checks and budget justification review. Layer the 37-month resubmission window and the 2026 policy changes above onto that grid, and the office has one reference that survives staff turnover rather than living in an individual administrator’s inbox.
What is the NIH grant cycle?
The NIH grant cycle is the recurring three-round annual schedule — Cycle I, II and III — that governs when applications are due, when they undergo scientific merit review, when an advisory council considers them, and the earliest date a project can start, typically nine months after submission.
When are NIH R01 grants due in 2026?
New R01 applications are due 5 February, 5 June and 5 October in each cycle. Renewal, resubmission and revision R01 applications use a separate schedule of 5 March, 5 July and 5 November — one month later than new applications in the same cycle.
How many times can you resubmit an NIH grant application?
NIH allows one resubmission per original application, designated A1. It must be submitted within 37 months of the original A0 submission date. A second unsuccessful attempt requires starting over as a new A0 application rather than a further resubmission.
What time are NIH grant applications due?
NIH applications and all associated documents, including reference letters, are due by 5:00 PM local time of the applicant organisation on the specified due date, regardless of the submitting institution’s time zone or the funding institute’s location.
None of this replaces reading the specific funding opportunity announcement, which can override standard due dates for a given mechanism or institute. But a shared, cycle-based master calendar — rather than a single-deadline mindset — is what actually scales when an office is tracking ten PIs instead of one, and it is the structural gap the 2026 policy tightening makes newly costly to leave unfilled.
